The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Karen, about 6m ago when I was angling for a 'flu' jab (got), my GP observed, "If you get 'flu' and Covid, then it's Goodnight Vienna." He had Covid himself a year back, comes from meeting so many ill people: not so severe, he continued working from home. He's a bit younger than I.
Good after to you K. Yes I can see that ,but if they give a PCR test and it's negative then you have already eliminated covid from the diagnosis ?
Kaeren, I think it was Taylor Quant on Twitter who suggested an 18 month shelf life for Winterplex but I can't find the tweet now.
Afternoon V , in winter the hospitals are full of patients with severe flu / pneumonia , the last thing you want to give them is covid too , they have to be isolated from each other.
I agree with most of what you have written K.
But this one has always bothered me. You are feeling poorly and have a test for covid with PCR and it's negative why the need for a test for flu ?
So what is the point of Winterplex ??
Am I being thick ?
I have read everyone's posts and just a couple of simple observations.
The government is reliant upon the vaccine rollout success to open up society.
Both Whitty and Valance have made their reservations clear. I to date have seen no comprehensive data surrounding longevity of antibodies after been vaccinated at 3 months 6 months etc. It is too soon to know but looking at Chile it does not bode well. Looking at Europe who came out of lockdown earlier then us, then the situation is far from rosy. Winterplex a supposed big earner was not utilised at all in the UK as we were in lockdown. Nova sold vast quantities of Winterplex to the DHSc it was part of the Sept 29th contract , they had to produce and deliver x every week for 14 weeks as they also had to with numerous other products. Just isolating the Winterplex for a moment , what was its shelf life , can it be used next winter , because rest assured flu has not miraculously vanished it will be back with a vengence once lockdown is lifted. Then there has to be a test to differentiate between flu and covid. Whose test are the DHSc sitting on right now, ours. Who has stockpiled Promate the DHSc. These tests will be used dates permitting and those that use them the NHS will look to procure more.
They are relying on pushing testing into private practice as it is cheaper. I strongly believe for the reasons quoted in my lengthy mail yesterday that this dispute will resolve quickly. Obviously it revolves around either out of date stock , refusal to pay for Promate to replace other assays , refusal to pay or want refund on initial assays. The govt ordered them, Nova produced a set amt as stipulated in the contract each week for up to 14 weeks ,
If the govt then changes its mind and wants another product it highly probably stipulates they can swap out for others but there will be a clause about the notification required because of the manufacturing process involved. I have seen many such disputes and Mullis cannot disclose details and has to warn of worst case scenario , it would be dishonest not to and I do not doubt his integrity. From my viewpoint I think it will be extremely difficult to wriggle out of this contract but hell they will give it a go and Mullis has stood his ground.
I keep hearing 50 % loss of business that can change very quickly especially as his focus and that of his team will now be on INT sales. Ncyt are very lucky to have a silver circle lawyer inhouse again a very wise move by Mullus as to engage a firm such as H.Smith would cost an absolute fortune , his foresight has meant we are not exposed to such costs. I expect the Sp to be volatile for a few weeks and our lovely new never posted here before bot flies to increase activity.
The reasons I invested remain the same and hell yeah wish I'd sold at 12 but I wont be giving my shares away at this price , Nova train in repair shop having fancy new respray so it can it can hit the tracks running
mirror...They are rolling out the vaccine no need for testing anymore!? So short sighted.
No need for covid testing, maybe. But not this year. And then what? What about testing for vaccine efficiency. What about variants, Diabetes, cancer, very other disease out there?
Novacyt is not a one trick covid pony. And novacyt is DEFINITELY NOT a one contract, one customer, one product, one year pony either.
As a trade it’s over. Fast money dream chasers will F off and go to the next pump and dump get rich quick scheme. As an investment for multi year wealth creation it’s the very start.
As sure as night follows day, there are 3 things certain in life:
1 death
2 taxes
3 dumb ass, impatient, financially illiterate, fast money, dream chasing gamblers pretending they have a clue what they are doing on the retail AlM market.
Buddy, you don’t know preferred stock from live stock. Stick to the casino.
Only trying to help people see sense!
Mirror123456
Go back into your little hole you sad deramper
Do people get tested for a cold or do they just have the flu jab and if feel ill a lemsip!!!
WBAFC : It may be a good reason to release a RNS to tell us what's coming and when.
We need some crumb of comfort from the bod's
They are rolling out the vaccine!!!! No need for huge amounts of testing anymore. Move on sell up as this will drop further
The fall in share price on Friday was dramatic ,oversold and played out by market makers to take out weak share holders . This is how market makers play their games to make money !
The fact remains clear that novocyt have been generating revenues just under £1M / day over Q1 . This is amazing and proves novocyt are way ahead of the game with others trying to still make money. It is a company that is doing brilliant !
Now that novocyt are not extending services for the DHSC , novocyt can and will concentrate more resources , and tap into the private and international market sectors to replace that missing 50% shortfall from the DHSC contract. The world covid-19 diagnostic PCR testing and private sector markets are far more lucrative than this DHSC contract.
There is £70B revenue of covid-19 diagnostic testing to tap into from international and private covid-19 diagnostic testing .
Look at the R&D RNS 24th February 2021 in detail and its exciting read. I have taken an extract from it :
'' Of note, following its launch, our PROmate™ test has been well received by users and opens up new opportunities for rapid PCR testing, including in private testing markets. In addition, we look forward to presenting exciting long-term plans for Novacyt during Q2 this year as we continue to define our strategy for delivering sustainable, long-term growth."